With support from the Centers for Disease Control and Prevention (CDC), Illumina and Helix have already identified more than 50 cases of the new variant in the US SAN DIEGO–Illumina, Inc. (Nasdaq: ILMN) and Helix today announced a collaboration to augment national surveillance infrastructure in the US to track the emergence and prevalence of novel […]
On January 4, 2021, Analytical BioSciences, a single-cell genomics and discovery company, launched OmniBrowser™, a comprehensively curated single cell data compendium with visualization and analysis capabilities that further empower innovative drug discovery and development. “Single cell genomics is becoming a cornerstone for drug discovery and development, clinical diagnosis and scientific research. I hope that OmniBrowser™ […]
WALTHAM, Mass. — Thermo Fisher Scientific, the world leader in serving science, today announced it has completed the acquisition of Phitonex, Inc., a Durham, North Carolina-based company that has pioneered a spectral dye platform for high-resolution biology applications designed to accelerate research and development in cell therapy, immuno-oncology and immunology research. Phitonex’s product offering will enable Thermo […]
SAN DIEGO — Bionano Genomics, Inc. (Nasdaq: BNGO), announced today that Nasdaq has granted the Company an additional 180-day compliance period, or until June 28, 2021, to regain compliance with Nasdaq’s minimum $1.00 closing bid price per share requirement. Nasdaq’s determination is based on the Company meeting the continued listing requirement for market value of […]
TUCSON, Ariz. — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that it has received notification of the issuance of Canadian patent number 2877729 for “Nuclease Protection Methods for Detection of Nucleotide Variants.” The patented technology involves a nuclease protection method using wildtype […]
— VUI-202012/01 Variant May Increase SARS-CoV-2 Transmissibility by 70% — — Controls to be Used to Develop, Verify and Validate Tests that Identify More Transmissible Variant — SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today […]
Murrieta Genomics has announced that SimplSeq, Inc., a wholly owned subsidiary, has filed its fourth patent application to protect a new sample preparation technology that is designed to simplify the process for extracting, isolating, purifying and replicating DNA and RNA from biologic samples. “Our internal validation testing has delivered some very exciting data, and we […]
Used with STRmix™, Software Enables Rapid Analysis of DNA Profiles WASHINGTON (PRWEB) December 22, 2020 FaSTR™ DNA, expert forensic software that rapidly analyzes DNA profiles and can assign a Number of Contributors (NoC) estimate, is now available commercially. The wider release of FaSTR™ DNA to the forensic and education/research community comes six months after its […]
— State-of-the-Art Site Near Portland, Oregon Expected to More than Double Manufacturing Capacity, Increase Speed of Production and Enable Enhanced Product Offerings — SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced plans to expand its manufacturing […]
Edinburgh, Scotland UK Arrayjet, the Scottish-based bio-printing and microarray technology company, has announced the appointment of its new non-executive Chairman. Dr Joe Keegan, a San Francisco-based biotechnology entrepreneur and one of the most respected leaders in the global life sciences industry, will replace Edinburgh-based serial entrepreneur and business strategist Alan Faichney, who is stepping down as […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
